Table 2 Patient Characteristics
From: Behavioral activation therapy for depression and anxiety in cancer patients: a case series study
No. | Age | Sex | Cancer type | Stage | Treatment | Psychiatric diagnosis | Antidepressant/ Stabilizer | Medication adjustment | PHQ-9 | GAD-7 | CGI-I | Complete or | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
pre | post | pre | post | Drop out | ||||||||||
1 | 45 | F | Breast cancer | II | Chemotherapy | Depression (moderate) | Escitalopram | Yes (discontinue) | 15 | 2 | 8 | 4 | 2 | Complete |
2 | 62 | F | Lung cancer | IV | Chemotherapy | Depression (moderate) | Escitalopram Lorazepam | Yes (increase) | 15 | 1 | 15 | 2 | 1 | Complete |
3 | 48 | F | Breast cancer | IV | Chemotherapy | Depression (moderate) | Mirtazapine | Yes (new prescription) | 13 | × | 3 | × | × | Drop out (brain metastasis) |
4 | 66 | F | Endometrial cancer | III | Chemotherapy | Depression (severe) | Escitalopram Alprazolam | Yes (increase) | 19 | 19 | 19 | 18 | 3 | Complete |
5 | 66 | F | Ovarian cancer | Recurrence | Chemotherapy | Depression (moderate) | Nothing | No | 14 | 2 | 8 | 0 | 1 | Complete |
6 | 72 | F | Breast cancer | IV | Chemotherapy | Adjustment disorder (with anxiety) | Nothing | No | 6 | 1 | 6 | 0 | 1 | Complete |
7 | 56 | F | Breast cancer | I | Observation | Adjustment disorder (with anxiety) | Nothing | No | 6 | 3 | 10 | 4 | 2 | Complete |
8 | 57 | F | Breast cancer | II | Chemotherapy | Adjustment disorder (with anxiety) | Ethyl loflazepate Alprazolam | No | 20 | 4 | 18 | 6 | 1 | Complete |
9 | 62 | M | Laryngeal cancer | Recurrence | Observation | Depression (moderate) | Escitalopram Ethyl loflazepate | No | 24 | 9 | 15 | 6 | 1 | Complete |
10 | 44 | F | Breast cancer | II | Chemotherapy | Depression (moderate) | Nothing | No | 11 | 5 | 8 | 2 | 2 | Complete |